Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 2
1951 1
1953 2
1955 1
1956 2
1957 4
1958 1
1959 1
1960 15
1961 7
1962 9
1963 9
1964 7
1965 15
1966 13
1967 11
1968 10
1969 11
1970 12
1971 10
1972 8
1973 25
1974 14
1975 24
1976 20
1977 18
1978 19
1979 21
1980 27
1981 25
1982 24
1983 22
1984 18
1985 20
1986 29
1987 30
1988 62
1989 71
1990 76
1991 70
1992 96
1993 83
1994 82
1995 80
1996 83
1997 104
1998 101
1999 124
2000 149
2001 145
2002 158
2003 142
2004 182
2005 194
2006 180
2007 219
2008 224
2009 238
2010 265
2011 266
2012 289
2013 341
2014 369
2015 430
2016 514
2017 554
2018 616
2019 667
2020 809
2021 934
2022 1051
2023 945
2024 974
2025 998
2026 685

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,486 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Ghoroori
Page 1
Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.
Rayner DG, Ferri DM, Guyatt GH, O'Byrne PM, Brignardello-Petersen R, Foroutan F, Chipps B, Sumino K, Perry TT, Nyenhuis S, Oppenheimer J, Israel E, Hoyte F, Rivera-Spoljaric K, McCabe E, Rangel S, Shade LE, Press VG, Hall L, Sue-Wah-Sing D, Melendez A, Orr H, Winders T, Gardner DD, Przywara K, Rank MA, Bacharier LB, Mosnaim G, Chu DK. Rayner DG, et al. JAMA. 2025 Jan 14;333(2):143-152. doi: 10.1001/jama.2024.22700. JAMA. 2025. PMID: 39465893 Free PMC article.
OBJECTIVE: To compare short-acting beta agonists (SABA) alone with SABA combined with inhaled corticosteroids (ICS) and with the fast-onset, long-acting beta agonist formoterol combined with ICS for asthma. ...STUDY SELECTION: Pairs of reviewers independently select …
OBJECTIVE: To compare short-acting beta agonists (SABA) alone with SABA combined with inhaled corticosteroids (ICS) and with t …
The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG, Beasley R. Krings JG, et al. J Allergy Clin Immunol Pract. 2024 Apr;12(4):870-879. doi: 10.1016/j.jaip.2024.01.011. Epub 2024 Jan 17. J Allergy Clin Immunol Pract. 2024. PMID: 38237858 Free PMC article. Review.
These recommendations are based on the risks of SABA monotherapy, the evidence that ICS-formoterol reliever therapy markedly decreases the occurrence of severe asthma exacerbations compared with SABA reliever therapy alone, and because ICS-formoterol reliever therap …
These recommendations are based on the risks of SABA monotherapy, the evidence that ICS-formoterol reliever therapy markedly decrease …
Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis.
Tsao CL, Chan SY, Lee MH, Hsieh TYJ, Phipatanakul W, Ruran HB, Ma KS. Tsao CL, et al. Allergy. 2025 Jun;80(6):1629-1646. doi: 10.1111/all.16538. Epub 2025 Jun 10. Allergy. 2025. PMID: 40491263 Free PMC article.
INTRODUCTION: The 2019 Global Initiative for Asthma (GINA) report no longer recommended short-acting beta-agonists (SABA) monotherapy due to associated complications and a lack of anti-inflammatory properties. This systematic review and meta-analysis aimed to evaluate adve …
INTRODUCTION: The 2019 Global Initiative for Asthma (GINA) report no longer recommended short-acting beta-agonists (SABA) monotherapy …
Overuse of short-acting β2-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme.
Nwaru BI, Ekström M, Hasvold P, Wiklund F, Telg G, Janson C. Nwaru BI, et al. Eur Respir J. 2020 Apr 16;55(4):1901872. doi: 10.1183/13993003.01872-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 31949111 Free PMC article.
BACKGROUND: Overuse of short-acting beta(2)-agonists (SABA) may indicate poor asthma control and adverse health outcomes. Contemporary population-based data on use, risk factors and impact of SABA (over)use on asthma exacerbations and mortality are scarce, prompting …
BACKGROUND: Overuse of short-acting beta(2)-agonists (SABA) may indicate poor asthma control and adverse health outcomes. Contemporar …
Expert Consensus on SABA Use for Asthma Clinical Decision-Making: A Delphi Approach.
Lugogo N, O'Connor M, George M, Merchant R, Bensch G, Portnoy J, Oppenheimer J, Castro M. Lugogo N, et al. Curr Allergy Asthma Rep. 2023 Nov;23(11):621-634. doi: 10.1007/s11882-023-01111-z. Epub 2023 Nov 22. Curr Allergy Asthma Rep. 2023. PMID: 37991672 Free PMC article. Review.
RECENT FINDINGS: In Phase 1 (n = 100 clinicians), 12% routinely provided patients with 4 SABA prescriptions/year, 73% solicited SABA use frequency at every patient visit, and 21% did not consult asthma guidelines/expert reports. Phase 3 experts (n = 8) reached cons …
RECENT FINDINGS: In Phase 1 (n = 100 clinicians), 12% routinely provided patients with 4 SABA prescriptions/year, 73% solicited S …
Landscape of short-acting beta-agonists (SABA) overuse in Europe.
de Las Vecillas L, Quirce S. de Las Vecillas L, et al. Clin Exp Allergy. 2023 Feb;53(2):132-144. doi: 10.1111/cea.14250. Epub 2022 Dec 5. Clin Exp Allergy. 2023. PMID: 36468654 Review.
Almost a third of European patients with asthma, at all severity levels, overuse SABA. Guidelines recommend close monitoring of patients who overuse SABA and avoiding over-reliance on SABA monotherapy. ...Changes in physician and patient behaviours towards …
Almost a third of European patients with asthma, at all severity levels, overuse SABA. Guidelines recommend close monitoring of patie …
The teacher-mentee bond in medicine.
Saba L. Saba L. Neuroradiol J. 2025 Feb;38(1):5-6. doi: 10.1177/19714009251316380. Epub 2025 Jan 21. Neuroradiol J. 2025. PMID: 39835921 Free PMC article. No abstract available.
Arrhythmia Ablation at the Summit.
Saba M. Saba M. JACC Clin Electrophysiol. 2026 Apr;12(4):782-784. doi: 10.1016/j.jacep.2026.01.016. JACC Clin Electrophysiol. 2026. PMID: 42047421 No abstract available.
Luca Saba.
[No authors listed] [No authors listed] Lancet Neurol. 2019 Jun;18(6):527. doi: 10.1016/S1474-4422(19)30114-0. Lancet Neurol. 2019. PMID: 31122492 No abstract available.
The management of mild asthma.
O'Byrne PM, Reddel HK, Beasley R. O'Byrne PM, et al. Eur Respir J. 2021 Apr 8;57(4):2003051. doi: 10.1183/13993003.03051-2020. Print 2021 Apr. Eur Respir J. 2021. PMID: 33093120 Free article. Review.
Asthma patients can find adhering to daily preventative medication with ICS difficult and will often revert to using as-needed SABA as their only treatment, increasing their risk of exacerbations. The purpose of this review is to evaluate the efficacy of reliever medicatio …
Asthma patients can find adhering to daily preventative medication with ICS difficult and will often revert to using as-needed SABA a …
12,486 results
You have reached the last available page of results. Please see the User Guide for more information.